Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Ibanez

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Biorxiv : the Preprint Server for Biology|November 14, 2023
Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer diseaseJiaxin Cindy Tu, Peter R Millar, Jeremy F Strain, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumNelly Joseph-Mathurin, Charles D Chen, Diana A Hobbs, et al.
Network Neuroscience (Cambridge, Mass.)|December 30, 2024
Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer's diseaseJiaxin Cindy Tu, Peter R Millar, Jeremy F Strain, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJulie K Wisch, Ziqiao Jiao, Patrick J Lao, et al.
The Journal of Prevention of Alzheimer'S Disease|March 21, 2025
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseDavid M Cash, Katy E Morgan, Antoinette O'Connor, et al.
The Lancet. Neurology|May 13, 2026
Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association studyMaulikkumar Patel, Wei Feng, Nicole S Mckay, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseDavid M Cash, Katy E Morgan, Antoinette O'Connor, et al.
European Urology Oncology|January 31, 2025
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission TomographyGiorgio Gandaglia, Francesco Barletta, Simone Scuderi, et al.
European Urology Oncology|June 3, 2023
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel ToolGiorgio Gandaglia, Francesco Barletta, Daniele Robesti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 25, 2025
Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's diseaseJulie K Wisch, Nicole S McKay, Matthew Zammit, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Biorxiv : the Preprint Server for Biology|November 14, 2023
Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer diseaseJiaxin Cindy Tu, Peter R Millar, Jeremy F Strain, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumNelly Joseph-Mathurin, Charles D Chen, Diana A Hobbs, et al.
Network Neuroscience (Cambridge, Mass.)|December 30, 2024
Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer's diseaseJiaxin Cindy Tu, Peter R Millar, Jeremy F Strain, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJulie K Wisch, Ziqiao Jiao, Patrick J Lao, et al.
The Journal of Prevention of Alzheimer'S Disease|March 21, 2025
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseDavid M Cash, Katy E Morgan, Antoinette O'Connor, et al.
The Lancet. Neurology|May 13, 2026
Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association studyMaulikkumar Patel, Wei Feng, Nicole S Mckay, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseDavid M Cash, Katy E Morgan, Antoinette O'Connor, et al.
European Urology Oncology|January 31, 2025
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission TomographyGiorgio Gandaglia, Francesco Barletta, Simone Scuderi, et al.
European Urology Oncology|June 3, 2023
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel ToolGiorgio Gandaglia, Francesco Barletta, Daniele Robesti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 25, 2025
Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's diseaseJulie K Wisch, Nicole S McKay, Matthew Zammit, et al.
Pageof 11